Reveal LINQ vs cV8 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Reveal LINQ

by Medtronic

cV8 Diagnostic Ultrasound System

by Samsung Healthcare

AI Verdict

Tool A, the Medtronic Reveal LINQ, is an implantable cardiac monitor that uses AI for continuous ECG recording and arrhythmia detection over extended periods. In contrast, Tool B, the Samsung Medison cV8 Diagnostic Ultrasound System, is a mobile ultrasound system that employs AI to enhance image quality and assist with real-time diagnostic measurements across various specialties. While both leverage AI in healthcare and share some specialty overlaps like cardiology and neurology, their core functionalities—long-term rhythm monitoring versus real-time diagnostic imaging—are fundamentally different.

Choose Reveal LINQ if…

Choose Reveal LINQ if you require long-term, continuous cardiac monitoring for patients experiencing infrequent or unexplained symptoms such as syncope, palpitations, or suspected cryptogenic stroke, where intermittent monitoring has been inconclusive. Its implantable nature and AI-powered algorithms provide discreet, highly accurate ECG data over up to three years, ideal for diagnosing elusive arrhythmias.

View Reveal LINQ →

Choose cV8 Diagnostic Ultrasound System if…

Choose the cV8 Diagnostic Ultrasound System if your clinical setting demands a premium, mobile ultrasound solution offering superior image quality and advanced AI-based diagnostic assistance across diverse specialties like neurology, obstetrics, and radiology. It is particularly well-suited for real-time imaging needs where enhanced clarity, detailed microvascular flow visualization, and intelligent tools for measurements and annotations can significantly boost diagnostic confidence and workflow efficiency.

View cV8 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Reveal LINQ	cV8 Diagnostic Ultrasound System
Pricing	Unknown	Varies
Deployment	The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.	On-premise (hospital environments and outpatient diagnostic clinics)
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Reveal LINQ

The Reveal LINQ (Tool A) offers superior patient usability due to its minimally invasive, implantable nature and continuous, passive monitoring for up to three years. Clinicians benefit from wireless data transmission to the CareLinku2122 network and a mobile app for remote device management, simplifying long-term cardiac surveillance and reducing the need for frequent in-person visits.

Clinical Value

Reveal LINQ

The Reveal LINQ (Tool A) provides unique clinical value by offering continuous ECG monitoring for up to three years, which is crucial for diagnosing elusive cardiac arrhythmias like atrial fibrillation, cryptogenic stroke, and unexplained syncope. Its AccuRhythmu2122 AI algorithms significantly reduce false alerts, improving diagnostic accuracy and clinician efficiency in identifying critical cardiac events.

Pricing & Value

Tie

Both tools require direct vendor contact for pricing, which is standard for advanced medical devices, and neither provides publicly disclosed pricing details. While Tool A mentions insurance coverage, this is a common expectation for such medical technologies. Without specific cost or detailed value-for-money comparisons, it is not possible to determine a winner.

Enterprise Readiness

Reveal LINQ

Both tools demonstrate strong enterprise readiness with FDA clearance and HIPAA compliance. However, Tool A's deployment as an implantable device with remote monitoring via a mobile app and the CareLinku2122 network offers a modern, scalable approach to patient data management and integration into existing clinical workflows.

Innovation

cV8 Diagnostic Ultrasound System

The cV8 Diagnostic Ultrasound System (Tool B) showcases a broader range of AI and imaging innovations, including advanced Crystal Architectureu2122 for superior image quality and a diverse suite of AI-based diagnostic assistance tools across multiple specialties. While Tool A's miniaturization and AI for false alert reduction are innovative, Tool B's comprehensive technological advancements in real-time diagnostics are more extensive and versatile.

Support & Docs

Tie

The provided information does not contain specific details regarding support and documentation for either product. Both Medtronic and Samsung Medison are established global medical technology companies, implying robust support infrastructures for their respective devices. Without further distinguishing information, a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Reveal LINQ	cV8 Diagnostic Ultrasound System
Name	Reveal LINQ	cV8 Diagnostic Ultrasound System
Company	Medtronic	Samsung Medison Co.
Device Type	Implantable Cardiac Monitor	Mobile Diagnostic Ultrasound System
Core Functionality	Continuous ECG monitoring for up to three years, detecting cardiac arrhythmias	Premium diagnostic ultrasound with advanced image quality and AI-based assistance
AI Algorithms/Assistance	AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause)	NerveTracku2122, UterineAssistu2122, BiometryAssistu2122, ViewAssistu2122, HeartAssistu2122
Specialties	Cardiology, Neurology	Neurology, Obstetrics & Gynecology, Radiology
Key Differentiator	World's smallest insertable cardiac monitor (1.2 mL)	Crystal Architectureu2122 for superior image clarity and penetration

Videos

Demos, reviews, and walkthroughs featuring Reveal LINQ and cV8 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications for which the Reveal LINQ and the cV8 Diagnostic Ultrasound System are designed?

The Medtronic Reveal LINQ is a tiny, implantable cardiac monitor designed for continuous ECG recording to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope, for up to three years. In contrast, the Samsung Medison cV8 Diagnostic Ultrasound System is a premium, mobile ultrasound system featuring advanced imaging and AI-based diagnostic assistance tools to enhance clinical confidence and workflow efficiency across diverse medical specialties such as Neurology, Obstetrics & Gynecology, and Radiology.

How do the AI functionalities of the Reveal LINQ and the cV8 system differ in their clinical purpose?

The Reveal LINQ utilizes AccuRhythmu2122 AI algorithms to reduce false alerts for atrial fibrillation and pauses, thereby improving information accuracy and saving clinicians time. The cV8 Diagnostic Ultrasound System incorporates AI-based Intelligent Assist solutions like NerveTracku2122 for nerve detection, UterineAssistu2122 for uterus measurement, BiometryAssistu2122 and ViewAssistu2122 for fetal growth and annotation, and HeartAssistu2122 for fetal heart diagnosis, aiming to enhance image analysis and workflow.

Can the cV8 Diagnostic Ultrasound System be used for continuous, long-term cardiac rhythm monitoring similar to the Reveal LINQ?

No, the cV8 Diagnostic Ultrasound System is a diagnostic imaging tool for real-time ultrasound examinations across various specialties, including some cardiac applications like fetal heart diagnosis. It is not designed for continuous, long-term cardiac rhythm monitoring, which is the specific function of the implantable Reveal LINQ.

What are the primary advantages of the Reveal LINQ's continuous ECG monitoring for up to three years?

The Reveal LINQ offers continuous ECG monitoring for up to three years, enabling the detection and diagnosis of infrequent or asymptomatic cardiac arrhythmias that might be missed by episodic diagnostic methods. Its AccuRhythmu2122 AI algorithms further enhance accuracy by reducing false alerts for AF and pauses, saving clinical review time.

Are there any overlapping specialties or complementary uses between these two distinct medical devices?

Both tools list Neurology as a specialty, with Reveal LINQ addressing cryptogenic stroke and unexplained syncope, and cV8 featuring NerveTracku2122 for nerve detection. While the cV8 is categorized under 'Cardiology AI' and includes HeartAssistu2122 for fetal heart diagnosis, its primary cardiac application is distinct from the Reveal LINQ's focus on long-term adult cardiac arrhythmia monitoring.